STERIS plc (STE) Valuation
Historical valuation analysis based on 1280 data points (2021-09-13 to 2026-10-16)
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring t...
STERIS plc (STE) currently trades at a P/E ratio of 26.97 (historical range: 24.83–122.46, median: 66.57), placing it at the 4th percentile — cheap relative to its history, P/S ratio of 3.60 (range: 3.31–8.04, 6th percentile — cheap relative to its history), EV/EBITDA of 20.39 (range: 18.88–157.22, 4th percentile).
Over the historical period (2021-09-13 to 2026-10-16), STERIS plc's P/E ratio has contracted by 41% over the observed period (from an average of 90.2 to 52.8).
STERIS plc trades well below its historical valuation range across most metrics.
Historical Valuation Metrics
| Metric | Current | Median | %ile | Assessment |
|---|---|---|---|---|
| P/E Ratio | 26.97 | 66.57 | 4th | cheap relative to its history |
| P/S Ratio | 3.60 | 5.20 | 6th | cheap relative to its history |
| EV/EBITDA | 20.39 | 42.57 | 4th | cheap relative to its history |
| FCF Yield | 4.26% | 2.19% | 96th | cheap relative to its history |
STERIS plc (STE) Valuation & P/E History
STERIS plc (STE) is a US-listed stock operating in the Healthcare sector, specifically the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry currently trading at $222.66 with a market capitalization of $21.7 billion. This page provides historical valuation analysis for STE based on 1280 data points covering 2021-09-13 to 2026-10-16. The P/E ratio of 26.97 is below the historical median of 66.57, placing STE at the 4th percentile of its valuation range. The P/S ratio of 3.60 compares to a median of 5.20.
STE Valuation Metrics & Historical Range
The valuation table above shows STERIS plc's current and historical valuation multiples, including P/E ratio, P/S ratio, EV/EBITDA, FCF yield, and dividend yield. Each metric is compared to its own historical range to determine whether STE is currently trading above or below its typical valuation levels.
- P/E ratio: Price-to-earnings measures how much investors pay per dollar of earnings. A P/E above the historical median suggests STE is expensively valued; below the median suggests it is cheap.
- P/S ratio: Price-to-sales is useful for companies with volatile or negative earnings. Lower P/S relative to history may indicate value.
- EV/EBITDA: Enterprise value to EBITDA adjusts for debt and cash, providing a capital-structure-neutral valuation measure for STERIS plc.
- FCF yield: Free cash flow yield shows the cash return relative to market price. Higher yields may indicate undervaluation.
Is STE Overvalued or Undervalued?
STERIS plc trades well below its historical valuation range across most metrics. The overall valuation percentile of 5 combines P/E, P/S, and EV/EBITDA percentiles into a single measure of how expensive STE is relative to its own history. A percentile below 25 suggests the stock may be undervalued, while a percentile above 75 suggests it may be overvalued.
However, valuation is only one factor in investment decisions. A stock can remain "overvalued" for years if growth accelerates, or "undervalued" if the business deteriorates. Always combine valuation analysis with financial statement analysis and the full STE analysis page for a complete picture.
Valuation data is computed from historical price and fundamental data via Polygon.io and Finnhub.STE trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.